Beijing, China

Zhenlan Du

This inventor holds 1 USPTO granted patent. Top assignee: Beijing Tiantan Hospital, Capital Medical University. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Zhenlan Du. Retrieved from https://idiyas.com/inventor/zhenlan-du

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Zhenlan Du: Innovator in Chimeric Antigen Receptor Technology

Introduction

Zhenlan Du is a prominent inventor based in Beijing, China. He has made significant contributions to the field of medical technology, particularly in the development of chimeric antigen receptors. His work is crucial in advancing therapeutic options for various diseases.

Latest Patents

Zhenlan Du holds a patent for an "Inducible Chimeric Antigen Receptor and Application Thereof." This innovative technology has the potential to enhance the effectiveness of immunotherapies, providing new avenues for treatment.

Career Highlights

Zhenlan Du is affiliated with Beijing Tiantan Hospital, which is part of Capital Medical University. His role at this esteemed institution allows him to engage in cutting-edge research and collaborate with other experts in the field.

Collaborations

He has worked alongside notable colleagues such as Jun Xu and Yanli Wang. Their combined expertise contributes to the advancement of research and development in their respective areas.

Conclusion

Zhenlan Du's contributions to the field of chimeric antigen receptor technology exemplify his commitment to innovation in medical science. His work continues to inspire advancements that may lead to improved patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…